Official Launch of the TWB Consortium to Accelerate Innovation in Industrial Biotechnology

TOULOUSE – OCTOBER 7, 2026

Philippe Mauguin, CEO of INRAE; Alexandra Bertron, director of INSA Toulouse; and Jocelyn Méré, CNRS regional delegate for Occitanie-Ouest, signed the new consortium agreement for TWB (Toulouse White Biotechnology)—the joint service unit that brings them together around biotechnology—on Wednesday, October 7, in Toulouse. With this signing, they officially launched the new phase initiated by the biotechnology incubator earlier this year, featuring a renewed and strengthened offering—particularly in its support for startups and a sustained collective drive for innovation.

Twb Signature Accord Consortium 2026

At a meeting on October 7 in Toulouse, TWB’s governing bodies reaffirmed their support for the biorefinery, which is implementing a new strategy closely aligned with the needs of manufacturers, companies, and startups.

Created in 2012 as part of the “Health and Biotechnology – Pre-industrial Demonstrators” call for projects under the Investment for the Future Program (PIA 3), TWB—which aligns with the leadership and sovereignty goals of France 2030—received a new grant in 2026 from the General Secretariat for Investment (SGPI), thereby encouraging its strategy of forging closer ties with manufacturers and supporting startups. With this new consortium agreement, which is valid for 10 years and renewable, the governing bodies—INRAE, INSA Toulouse, and CNRS—provide TWB with a legal framework that facilitates and strengthens collaboration with its members and partners and gives new momentum to the development of biotechnology.

In addition, they are strengthening the involvement of their research units through the creation of a scientific and technological council. Composed of nine researchers representing TWB’s scientific and technical expertise—metabolic engineering, genome and consortium engineering, fermentation, enzymatic catalysis and separation techniques, AI, and chemical and biological monitoring—this council will provide advice and propose new production strategies to reduce the industry’s environmental impact.

Bolstered by this support, TWB will continue the initiatives it launched this spring to accelerate industrial biotechnology within its core business.

A segmented offering designed to address the challenges of industrial biotechnology

TWB’s success is built on proven strengths. Thanks to streamlined contracting processes and pre-negotiated intellectual property terms, the agreement accelerates the launch of new projects. Through close collaborations with other stakeholders in the Toulouse Biotech Alley—the Toulouse Biotechnology Institute (TBI), CRITT Bio-Industries, and GPTE—membership provides privileged access to research and development support from organizations recognized throughout the sector, covering TRLs 1 through 7. Finally, its integration into the distributed European infrastructure IBISBA provides direct access to biotechnology expertise that is unique in Europe.

With this new agreement, TWB is taking its offering a step further with a differentiated and comprehensive approach. Members can now join the consortium at one of four levels based on their needs, maturity, and ambitions. Their membership will grant them access to a comprehensive suite of services that now includes—in addition to scientific and technological expertise—strategic, financial, and networking support, including feasibility studies, business and marketing consulting, technical-economic analyses, and life-cycle analyses.

More than twenty public and private entities have already expressed their interest in joining this diverse and dynamic community.

Ecosystem Innovation Through Communities of Interest

Now offering a structured framework for open innovation, TWB will launch its first community of interest dedicated to raw materials in industrial biotechnology on November 13, 2026. In these communities, about fifteen stakeholders—manufacturers, researchers, startups, and investors from various sectors—come together to tackle common challenges and develop solutions that none of them could achieve on their own. By combining collective thinking with experimentation, TWB aims to accelerate the emergence of high-impact collaborative projects for industrial biotechnology, while pooling resources and limiting risk-taking.

Comprehensive Support for Startups

Launched last July, the Smart-Up Ventures competition symbolizes TWB’s new support program for startups. Backed by three startup studios (4Elements, Technofounders, Agrilife Studio) and the SATT Toulouse Tech Transfer, the program complements its scientific and technological expertise with administrative, marketing, and financial support. Through this competition, the most promising startup founders will be selected to participate in a comprehensive, tailored training program designed to help them win over investors and partners. At the end of this training, on November 25, they will be invited to pitch to a jury of experts and consortium members, with the prospect of joining the consortium and collaborating directly with its members.

The goal: to support about fifteen startups by 2027, spearheaded by the future Halle Biotech at INSA Toulouse, which will open in the fall of 2027.

The support from INRAE, INSA Toulouse, and the CNRS, as demonstrated by this agreement, confirms the momentum TWB has gained in its role as a catalyst for an agile ecosystem and amplifies its drive to push the current boundaries of biotechnology and accelerate its growth in the industry of tomorrow.

« The ongoing support from our governing bodies enables us to provide the best possible backing for our private partners’ ambitions to compete effectively and achieve successful growth. Joining TWB means choosing a strong partner and taking part in a collective effort driven by a fierce determination to accelerate the development of biotechnology and the transition to a more sustainable world. » Pascal Chapon – CEO of TWB

« This consortium will enable us to accelerate the transition from research to innovation in biotechnology. By breaking down barriers between areas of expertise, TWB serves as a driving force for INRAE and its public and private partners, helping them more quickly transform scientific excellence into concrete innovations that create value and enhance France’s competitiveness. » Philippe Mauguin – CEO of INRAE

« We are delighted with this new agreement, which strengthens our long-standing partnership with INRAE and the CNRS. It reinforces INSA Toulouse’s ambition to make its campus an ecosystem of excellence where research, education, and innovation come together to advance the biotechnologies of tomorrow. Together with TWB and the future Halle Biotech, we aim to strengthen this collective momentum for the benefit of companies, startups, and our future engineers. » Alexandra Bertron – Director of INSA Toulouse

« Competitive innovation is necessarily driven by high-level research. With this new agreement for TWB, supported by the CNRS and its partners, the goal is to streamline the integration of the excellent basic research conducted by the entire scientific community with innovation and pre-industrial phases. » Lionel Buchaillot – Director, CNRS Engineering